ipharmacenter Consulting services

Eisai and Biogen have announced that the United Arab Emirates (UAE) Ministry of Health and Prevention has granted approval for Leqembi...

LEQEMBI (Lecanemab) Gains Approval in South Korea for Alzheimer’s Disease Treatment EiSai and Biogen have announced that South Korea's...

Eisai submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety (MFDS) to seek approval for...